Cancer Survivorship

  • Lisa M. RuppertEmail author
  • Gabrielle Miskovitz
  • Michael D. Stubblefield


Brain tumors can be primary, arising from neuroepithelial cells or secondary to metastatic disease, and can arise anywhere from the cerebral hemispheres above the tentorium to the posterior fossa. These tumors may cause destruction or displacement of normal brain tissue resulting in neurological compromise. Oncologic management of brain tumors includes surgical resection, radiation therapy and chemotherapy. Survival factors such as age, extent of systemic disease, neurological status at time of diagnosis, and number and sites of metastases are considered when determining optimal treatment. When combined with oncologic management, rehabilitation can serve to relieve symptoms, improve quality of life, enhance functional independence, and prevent further complications in patients with brain tumors.


Brain tumor Brain metastases Brain injury Cognitive dysfunction 


  1. Armstrong, C. L., Corn, B. W., Ruffer, J. E., Pruitt, A. A., Mollman, J. E., & Phillips, P. C. (2000). Radiotherapeutic effects on brain function: Double dissociation of memory systems. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 13(2), 101–111.PubMedGoogle Scholar
  2. Armstrong, T. S., & Gilbert, M. R. (2007). Net clinical benefit: Functional endpoints in brain tumor clinical trials. Current Oncology Reports, 9(1), 60–65.CrossRefPubMedGoogle Scholar
  3. Braddom, R. L. (Ed.). (2007). Physical medicine and rehabilitation (3rd ed.). Philadelphia: Saunders Elsevier.Google Scholar
  4. Christie, L. A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012). Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clinical Cancer Research, 18(7), 1954–1965. doi: 10.1158/1078-0432.CCR-11-2000.CrossRefPubMedGoogle Scholar
  5. Correa, D. D., DeAngelis, L. M., Shi, W., Thaler, H., Glass, A., & Abrey, L. E. (2004). Cognitive functions in survivors of primary central nervous system lymphoma. Neurology, 62(4), 548–555.CrossRefPubMedGoogle Scholar
  6. Correa, D. D., Shi, W., Abrey, L. E., Deangelis, L. M., Omuro, A. M., Deutsch, M. B., et al. (2012). Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-Oncology, 14(1), 101–108. doi: 10.1093/neuonc/nor186.CrossRefPubMedGoogle Scholar
  7. Cotran, R. S., Kumar, V., & Collins, T. (Eds.). (1999). Robbins pathologic basis of disease (6th ed.). Philadelphia: W.B. Saunders Company.Google Scholar
  8. Davis, M. P., Zimmermann, C., Feyer, P., & Ortner, P. (Eds.). (2011). Supportive oncology. Philadelphia: Elsevier.Google Scholar
  9. DeAngelis, L. M., Delattre, J. Y., & Posner, J. B. (1989). Radiation-induced dementia in patients cured of brain metastases. Neurology, 39(6), 789–796.CrossRefPubMedGoogle Scholar
  10. DeLisa, J. A. (2001). A history of cancer rehabilitation. Cancer, 92(4 Suppl), 970–974.CrossRefPubMedGoogle Scholar
  11. Dietz, J. H. (Ed.). (1981). Rehabilitation oncology. New York: John Wiley and Sons Inc.Google Scholar
  12. Gilbert, M., Armstrong, T., & Meyers, C. (2000). Issues in assessing and interpreting quality of life in patients with malignant glioma. Seminar in Oncology, 27(3 Suppl 6), 20–26.Google Scholar
  13. Giordana, M. T., & Clara, E. (2006). Functional rehabilitation and brain tumour patients. A review of outcome. Neurological Science, 27(4), 240–244. doi: 10.1007/s10072-006-0677-9.CrossRefGoogle Scholar
  14. Heilman, K. M., Watson, R. T., & Valenstein, E. (1993). Neglect and related disorders. Clinical Neuropsychology, 3, 279–336.Google Scholar
  15. Huang, M. E., Cifu, D. X., & Keyser-Marcus, L. (1998). Functional outcome after brain tumor and acute stroke: A comparative analysis. Archives of Physical Medicine and Rehabilitation, 79(11), 1386–1390.CrossRefPubMedGoogle Scholar
  16. Janda, M., Steginga, S., Dunn, J., Langbecker, D., Walker, D., & Eakin, E. (2008). Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Education and Counseling, 71(2), 251–258.CrossRefPubMedGoogle Scholar
  17. Kirshblum, S., O’Dell, M. W., Ho, C., & Barr, K. (2001). Rehabilitation of persons with central nervous system tumors. Cancer, 92(4 Suppl), 1029–1038.CrossRefPubMedGoogle Scholar
  18. Koretz, B. K., & Moore, A. A. (2001). Assessment of the geriatric patient: A practical approach. Journal of Clinical Outcomes Management, 8(7), 35–40.Google Scholar
  19. Lee, E. Q., Arrillaga-Romany, I. C., & Wen, P. Y. (2012). Neurologic complications of cancer drug therapies. Continuum (Minneap Minn), 18(2), 355–365. doi: 10.1212/01.CON.0000413663.42798.64.Google Scholar
  20. Lu-Emerson, C., & Eichler, A. F. (2012). Brain metastases. Continuum (Minneap Minn), 18(2), 295–311. doi: 10.1212/01.CON.0000413659.12304.a6.Google Scholar
  21. Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998). Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. Journal of Clinical Oncology, 16(7), 2522–2527.PubMedGoogle Scholar
  22. Mukand, J. A., Blackinton, D. D., Crincoli, M. G., Lee, J. J., & Santos, B. B. (2001). Incidence of neurologic deficits and rehabilitation of patients with brain tumors. American Journal of Physical Medicine and Rehabilitation, 80(5), 346–350.CrossRefPubMedGoogle Scholar
  23. Newton, H. B. (2012). Neurological complications of chemotherapy to the central nervous system. Handbook of Clinical Neurology, 105, 903–916. doi: 10.1016/B978-0-444-53502-3.00031-8.CrossRefPubMedGoogle Scholar
  24. O’Neill, B. P., Buckner, J. C., Coffey, R. J., Dinapoli, R. P., & Shaw, E. G. (1994). Brain metastatic lesions. Mayo Clinic Proceedings, 69(11), 1062–1068.CrossRefPubMedGoogle Scholar
  25. Ownsworth, T., Hawkes, A., Steginga, S., Walker, D., & Shum, D. (2008). A biopsychosocial perspective on adjustment and quality of life following brain tumor: A systematic evaluation of the literature. Disability and Rehabilitation, 29, 1–18.Google Scholar
  26. Patchell, R. A. (1996). The treatment of brain metastases. Cancer Investigation, 14(2), 169–177.CrossRefPubMedGoogle Scholar
  27. Raffa, R. B. (2011). A proposed mechanism for chemotherapy-related cognitive impairment (“chemo-fog”). Journal of Clinical Pharmacy and Therapeutics, 36(3), 257–259. doi: 10.1111/j.1365-2710.2010.01188.x.CrossRefPubMedGoogle Scholar
  28. Rogers, L. R. (2012). Neurologic complications of radiation. Continuum (Minneap Minn), 18(2), 343–354. doi: 10.1212/01.CON.0000413662.35174.a8.Google Scholar
  29. Stubblefield, M. D., & O’Dell, M. W. (Eds.). (2009). Cancer rehabilitation. New York: Demos Medical.Google Scholar
  30. Syrjala, K. L., Stover, A. C., Yi, J. C., Artherholt, S. B., & Abrams, J. R. (2010). Measuring social activities and social function in long-term cancer survivors who received hematopoietic stem cell transplantation. Psychooncology, 19(5), 462–471.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag New York 2017

Authors and Affiliations

  • Lisa M. Ruppert
    • 1
    Email author
  • Gabrielle Miskovitz
    • 2
  • Michael D. Stubblefield
    • 3
  1. 1.Memorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Memorial Sloan Kettering Cancer CenterNew YorkUSA
  3. 3.Kessler Institute for RehabilitationWest OrangeUSA

Personalised recommendations